Notably, Cav-1 levels are reduced in MMD patients carrying the RNF213 R4810K mutation [35], as well as in the lung tissue of RNF213 R4810K transgenic mice exposed to hypoxic stress [6]. The gene discussed is CAV1; the disease is multiminicore myopathy.